Form D · Other Health Care
ROSE DIAGNOSTICS INC.
Carlsbad, CA · CIK 0002027716
Offering snapshot reported Sep 15, 2026 · SEC filing
- Reported sold
- $2.21M Offering amount: $3M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Jul 10, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 15, 2026 | Initial | $2,208,750 | No comparison | 18 | SEC filing |
| May 13, 2025 | Initial | $2,344,375 | No comparison | 18 | SEC filing |
| Jun 21, 2024 | Initial | $1,005,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-597524
Source: Form D, filed Sep 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Brouwer | Director, Executive |
| Paul Gold | Director |
| Andrew Morris | Director, Executive |
| Donna Padavan | Director, Executive |
| Adolfo Velazquez | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2796 Loker Ave. W Suite 104
Carlsbad, CA, 92010
Carlsbad, CA, 92010